CD8A and neoplasm: High activated CD8+ cytotoxic lymphocytes (CTLs) in combination with low Tregs in tumor can improve both OS and disease-free survival (DFS) of patients, while CD4+ TILs, CD8+ TILs or CD3+ TILs had no effect on patients survival.